Skip to search formSkip to main contentSkip to account menu

SMYD3 gene

Known as: SET and MYND domain containing 3, KMT3E, SET AND MYND DOMAIN-CONTAINING PROTEIN 3 
This gene plays a regulatory role in histone methyltransferase activity and transcription.
National Institutes of Health

Related topics

Related topics

8 relations
Cell ProliferationMethylationSMYD3 protein, humanTranscriptional Activation

Narrower (1)

SMYD3 wt Allele

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
MP51-06 SMYD3 INHIBITION INDUCES PROTECTIVE AUTOPHAGY IN BLADDER CANCER VIA MTOR PATHWAY
INTRODUCTION AND OBJECTIVES: SMYD3, a histone H3K4 protein lysine methyltransferase, has a key role in activating of many… 
2016
2016
Novel insights into the oncogenic function of the SMYD3 lysine methyltransferase.
SMYD3 is a member of the SMYD family of lysine methyltransferases (KMTs). In humans, there are five SMYD members (SMYD1–5) that… 
2016
2016
Mechanism of gene-specificity of oncogenic regulators
The generation of cancer-specific gene expression patterns is attributed to aberrant activation of oncogenic transcription… 
2012
2012
The role of NeuroD1 in the upregulation of SMYD3 by HBx.
183 Background: SET and MYND Domain-Containing Protein 3 (SMYD3) is frequently overexpressed in hepatocellular carcinoma (HCC… 
Review
2011
Review
2011
Small changes for works.
The central dogma of molecular biology indicates that genetic information from DNA is transmitted to RNA, and then translated… 
2010
2010
Simultaneous expression of SMYD3 and EGFP in NIH3T3 cells
SET and MYND domain-containing protein 3 (SMYD3) is a novel histone methyltransferase involved in human carcinogenesis. To… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)